The clinicopathologic association of c-MET overexpression in Iranian gastric carcinomas; an immunohistochemical study of tissue microarrays
Open Access
- 28 May 2012
- journal article
- research article
- Published by Springer Nature in Diagnostic Pathology
- Vol. 7 (1) , 57
Abstract
C-MET is an oncogene protein that plays important role in gastric carcinogenesis and has been introduced as a prognostic marker and potential therapeutic target. The aim of this study was to evaluate the frequency of c-MET overexpression and its relationship with clinicopathological variables in gastric cancer of Iranian population using tissue microarray.Keywords
This publication has 49 references indexed in Scilit:
- Targeted Therapies and Predictive Markers in Epithelial Malignancies of the Gastrointestinal TractArchives of Pathology & Laboratory Medicine, 2012
- An inexpensive method of small paraffin tissue microarrays using mechanical pencil tipsDiagnostic Pathology, 2011
- Recombinant immunotoxin anti-c-Met/PE38KDEL inhibits proliferation and promotes apoptosis of gastric cancer cellsJournal of Experimental & Clinical Cancer Research, 2011
- Impact of MET amplification on gastric cancer: Possible roles as a novel prognostic marker and a potential therapeutic targetOncology Reports, 2011
- Gastric cancerCritical Reviews in Oncology/Hematology, 2009
- Appraisal of compliance with the UICC/AJCC staging system in the staging of gastric cancerBritish Journal of Surgery, 2002
- Absence oftpr-metand expression ofc-metin human gastric mucosa and carcinomaThe Journal of Pathology, 2001
- Somatic mutations of the MET oncogene are selected during metastatic spread of human HNSC carcinomasOncogene, 2000
- Frequent amplification of the c-met gene in scirrhous type stomach cancerBiochemical and Biophysical Research Communications, 1992
- The receptor encoded by the human C‐MET oncogene is expressed in hepatocytes, epithelial cells and solid tumorsInternational Journal of Cancer, 1991